...
首页> 外文期刊>Oncology letters >Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma
【24h】

Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma

机译:含趋化因子样的奇迹般的杂物跨膜结构域3表达与食管鳞状细胞癌的良好预后有关

获取原文
获取原文并翻译 | 示例

摘要

Decreased expression of human chemokine-like factor-like MARVEL transmembrane domain-containing 3 (CMTM3) has been identified in a number of human tumors and tumor cell lines, including gastric and testicular cancer, and PC3, CAL27 and Tca-83 cell lines. However, the association between CMTM3 expression and the clinicopathological features and prognosis of esophageal squamous cell carcinoma (ESCC) patients remains unclear. The aim of the present study was to investigate the correlation between CMTM3 expression and clinicopathological parameters and prognosis in ESCC. CMTM3 mRNA and protein expression was analyzed in ESCC and paired non-tumor tissues by quantitative real-time polymerase chain reaction, western blotting and immunohistochemical analysis. The Kaplan-Meier method was used to plot survival curves and the Cox proportional hazards regression model was also used for univariate and multivariate survival analysis. The results revealed that CMTM3 mRNA and protein expression levels were lower in 82.5% (30/40) and 75% (30/40) of ESCC tissues, respectively, when compared with matched non-tumor tissues. Statistical analysis demonstrated that CMTM3 expression was significantly correlated with lymph node metastasis (P=0.002) and clinical stage (P<0.001) in ESCC tissues. Furthermore, the survival time of ESCC patients exhibiting low CMTM3 expression was significantly shorter than that of ESCC patients exhibiting high CMTM3 expression (P=0.01). In addition, Kaplan-Meier survival analysis revealed that the overall survival time of patients exhibiting low CMTM3 expression was significantly decreased compared with patients exhibiting high CMTM3 expression (P=0.010). Cox multivariate analysis indicated that CMTM3 protein expression was an independent prognostic predictor for ESCC after resection. This study indicated that CMTM3 expression is significantly decreased in ESCC tissues and CMTM3 protein expression in resected tumors may present an effective prognostic biomarker.
机译:已经在许多人肿瘤和肿瘤细胞系中鉴定了含有人趋化因子样的奇迹跨膜结构域结构域结构域的3(CMTM3)的表达,包括胃和睾丸癌,以及PC3,CAL27和TCA-83细胞系。然而,CMTM3表达与食管鳞状细胞癌(ESCC)患者的临床病理特征和预后的关联尚不清楚。本研究的目的是探讨CMTM3表达与ESCC中的临床病理参数和预后之间的相关性。通过定量实时聚合酶链反应,Western印迹和免疫组化分析分析CMTM3 mRNA和蛋白质表达并配对非肿瘤组织。 KAPLAN-MEIER方法用于绘制存活曲线,COX比例危害回归模型也用于单变量和多变量存活分析。结果表明,与匹配的非肿瘤组织相比,CMTM3 mRNA和蛋白表达水平分别在82.5%(30/40)和75%(30/40)的ESCC组织中。统计学分析表明,CMTM3表达与ESCC组织中的淋巴结转移(P = 0.002)和临床阶段(P <0.001)显着相关。此外,表现出低CMTM3表达的ESCC患者的存活时间明显短于表现出高CMTM3表达的ESCC患者(P = 0.01)。此外,Kaplan-Meier生存分析显示,与表现出高CMTM3表达的患者相比,表现出低CMTM3表达的患者的整体存活时间显着降低(P = 0.010)。 Cox多变量分析表明CMTM3蛋白表达是切除后ESCC的独立预后预测因子。本研究表明,在ESCC组织中,CMTM3表达明显降低,切除肿瘤中的CMTM3蛋白表达可能出现有效的预后生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号